NEW YORK, Nov 10 – A jury delivered a mixed verdict in Oxford Gene Technology’s US patent infringement lawsuit against Affymetrix Friday, holding that Affymetrix did not willfully or literally infringe on OGT’s patents, but that it did infringe under a special rule called the " doctrine of equivalents,” Affymetrix reported.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

23andMe's Anne Wojcicki ponders DNA and what it means to be human in a New York Times essay.

A new estimate places the last universal common ancestor to life on Earth as living 3.9 billion years ago, Inverse reports.

In PNAS this week: retinitis pigmentosa gene therapy, role of microbiome in growth stunting, and more.

Bloomberg reports that researchers and drug companies are modeling anti-obesity treatments after the rare genetic condition essential fructosuria.